OpenAI's recent acquisition of Orchestra Bio signals advancements in AI-assisted drug development, potentially speeding up research and improving treatments.
An analysis of roughly 400,000 public forum posts written by people taking GLP-1 drugs has surfaced effects that feature little in the trial literature, including menstrual changes and…
A compound called AP503 built bone and slowed bone loss in animals by activating GPR133, a cell-surface receptor that has drawn little attention in skeletal research until now.
A small clinical trial suggests oral fecal microbiome transplantation (FMT), sometimes called “poop pills,” may raise peanut tolerance in some adults with peanut allergy, but the…
The FDA has approved SIMTRIYO, a new daily extended-release tablet containing centanafadine, as a treatment option for attention deficit hyperactivity disorder (ADHD) in adults and…
The Food and Drug Administration has approved an over-the-counter combination pill that pairs acetaminophen (Tylenol) with naproxen sodium (Aleve).
Hot weather can be more than uncomfortable — for people taking certain medicines, it can increase the risk of heat-related illness.
Summer heat can be more dangerous if you take certain medicines. Some drugs interfere with your body’s ability to cool itself, reduce thirst, or increase fluid loss — all of which…
Emmy-winning actor Mayim Bialik has described a severe reaction after a single low dose of a GLP-1 medication, leaving her with weeks of debilitating gastrointestinal symptoms.
A new oral medication, daraxonrasib, produced striking results in a phase 3 trial for people with pancreatic cancer, offering hope against one of the deadliest cancers.
Eli Lilly’s experimental drug retatrutide produced unprecedented weight loss in a phase 3 trial, with results that approach those seen after bariatric surgery and exceed outcomes from…
A new analysis of U.S. bariatric surgery data shows a notable decline in procedures as prescriptions for GLP‑1 weight-loss drugs and other nonsurgical programs have surged.